A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if TC-5214 or placebo (a tablet that looks like
medicine tablet or capsule, but contains no active medicine) is safe and effective when taken
together with another antidepressant.